100% Quality Guarantee
PhD-Level Technical Support
Key Features

Anti-Human CD119 (IFN-gamma Ralpha Chain) In Vivo Antibody - Ultra Low Endotoxin (IVMB0104)

SKU IVMB0104
Product Type In Vivo Monoclonal Antibody
Clone GIR-208
Protein IFN-gamma R-alpha
Isotype Mouse IgG1
Reactivity Human
Synonyms IFNGR1
Synonyms IFN-gammaR
Synonyms IFN-gammaRalpha
Synonyms IFN-alpha R1
Synonyms CDw119
Endotoxin Level Ultra Low Endotoxin
Host Species Mouse
Antibody Type Functional-Grade In Vivo Antibody
Applications In Vivo, FA, FC
Target / Synonyms::IFNGR1 · IFN-gammaR · IFN-gammaRalpha · IFN-alpha R1 · CDw119
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Anti-Human CD119 (IFN-γ Rα Chain) In Vivo Antibody - Ultra Low Endotoxin

Introducing the Anti-Human CD119 (IFN-γ R1 chain) In Vivo Antibody - Ultra Low Endotoxin from Assay Genie, a highly specific monoclonal antibody tailored for in vivo applications. This antibody targets the CD119 protein, which is a critical component of the interferon-gamma receptor, making it ideal for research in immunology and related fields. With a mouse IgG isotype, it ensures exceptional purity and ultra-low endotoxin levels (<0.02 EU/mg), perfect for ELISA, flow cytometry, immunohistochemistry, and other assays. Available in various sizes, it is formulated in phosphate-buffered saline for optimal stability and efficacy.

Enhance your research with this reliable and versatile antibody. CD119 is a receptor chain for interferon-gamma (IFN-γ), playing a key role in mediating the immune response to pathogens. It is found on the surface of various immune cells, including macrophages, dendritic cells, and natural killer cells. This receptor is essential for the activation and regulation of immune responses, particularly in host defense mechanisms against infections and cancer.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose